Skip to main content

Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II Study

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II Study

User login

Username

Password

Reset your password

Type	Lead	score